Related Experiment Videos
[Alterations in receptor status and signal transduction mechanisms in pituitary tumors]
1Department of Internal Medicine, Kyoto University Faculty of Medicine.
Abstract:
Recently evidence has been accumulating that important abnormalities in the receptor status and postreceptor signal transduction frequently occurred in human pituitary tumors. Several in vivo and in vitro studies suggest that during tumoral expansion, pituitary cells acquire functionally active receptors and respond to a variety of hypothalamic hormones. Alterations in proteins responsible for signal transduction have been reported. Somatic mutations of the alpha chain of Gs, the stimulatory regulatory protein of adenylate cyclase (AC), causing constitutive activation of AC have been identified in a subset of human GH-secreting adenomas. Alterations in receptor and signal transduction mechanisms in pituitary tumors triggered by hypothalamic hormones may result in amplification of stimulatory inputs and impairment of inhibitory inputs.
Insights
Human pituitary tumors show receptor and signal transduction abnormalities. These changes, including Gs protein mutations, can amplify hormonal signals, contributing to tumor growth.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Context:
- Human pituitary tumors frequently exhibit abnormalities in receptor function and postreceptor signal transduction pathways.
- Studies indicate that during tumor development, pituitary cells gain active receptors and respond to hypothalamic hormones.
- Altered signal transduction proteins are increasingly reported in pituitary adenomas.
Purpose:
- To investigate the role of receptor status and signal transduction in human pituitary tumors.
- To identify specific molecular alterations, such as Gs protein mutations, in pituitary adenomas.
- To understand how these changes affect cellular responses to hypothalamic hormones.
Summary:
- Accumulating evidence points to significant abnormalities in receptor status and postreceptor signal transduction in human pituitary tumors.
- Somatic mutations in the alpha chain of Gs, the stimulatory regulatory protein of adenylate cyclase (AC), lead to constitutive AC activation in some GH-secreting adenomas.
- These alterations can amplify stimulatory signals and impair inhibitory signals triggered by hypothalamic hormones, potentially driving tumor progression.
Impact:
- Understanding these molecular mechanisms is crucial for developing targeted therapies for pituitary tumors.
- Identifies specific molecular targets, like Gs protein, for therapeutic intervention.
- Provides insights into the pathogenesis of pituitary adenomas and their hormonal dysregulation.